How Much Did Olive Tree Compounding Pharmacy Raise?
Funding & Key Investors

Olive Tree Compounding Pharmacy has secured significant capital, with total funding reaching $150K and a recent major strategic investment of $150K. This latest financing round, which closed on March 31, 2024, underscores the company's established position in the specialized pharmaceutical sector and its trajectory for continued expansion. The infusion of capital is expected to fuel further development and market penetration.

What is Olive Tree Compounding Pharmacy?

Olive Tree Compounding Pharmacy
RetailDrug Stores & Pharmacies

Olive Tree Compounding Pharmacy is a specialized provider of personalized medications, focusing on tailored treatments for a diverse clientele. Their comprehensive services include hormone balance solutions, veterinary compounds, and unique specialty treatments. The pharmacy addresses a broad spectrum of patient needs, from pain management and sports medicine to dental formulations and pediatric innovations. By creating customized dosage forms, Olive Tree Compounding Pharmacy ensures that individual medicinal requirements are precisely met, serving men, women, pets, and patients requiring hospice care.

How much funding has Olive Tree Compounding Pharmacy raised?

Olive Tree Compounding Pharmacy has raised a total of $150K across 1 funding round:

2024

Debt

$150K

Debt (2024): $150K with participation from Colony Bank

Key Investors in Olive Tree Compounding Pharmacy

Colony Bank

Colony Bank, a financial institution, has provided debt financing, indicating a strategic partnership aimed at supporting Olive Tree Compounding Pharmacy's operational expansion and capital needs.

What's next for Olive Tree Compounding Pharmacy?

With its recent large-scale late-stage funding, Olive Tree Compounding Pharmacy is poised for significant growth and strategic advancements. The 'major strategic investment' suggests a focus on scaling operations, enhancing research and development in compounding techniques, and potentially expanding its service offerings or geographic reach. This capital infusion will likely enable the company to solidify its market leadership in personalized medicine and further innovate in creating bespoke pharmaceutical solutions, reinforcing its commitment to patient-specific care.

See full Olive Tree Compounding Pharmacy company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Retail industry

Grocery RetailRetail
Home Improvement & Hardware RetailRetail
Automobile DealersRetailAutomotive Service & Collision RepairConsumer Services
Department Stores, Shopping Centers & SuperstoresRetailManufacturingSporting & Recreational Equipment RetailSporting Goods

Frequently Asked Questions Regarding Olive Tree Compounding Pharmacy Financial Insights

What are the most recent funding rounds that Olive Tree Compounding Pharmacy has completed, and what were the funding rounds?
Olive Tree Compounding Pharmacy has recently completed 1 funding rounds: Debt on Mar 31, 2024.
What is the total amount of funding Olive Tree Compounding Pharmacy has raised to date?
Olive Tree Compounding Pharmacy has raised a total of $150K in funding to date.
How many funding rounds has Olive Tree Compounding Pharmacy completed?
Olive Tree Compounding Pharmacy has completed 1 funding rounds.
How much funding did Olive Tree Compounding Pharmacy raise in its most recent funding round?
Olive Tree Compounding Pharmacy raised $150K in its most recent funding round.
Who are the lead investors in Olive Tree Compounding Pharmacy's latest funding round?
The lead investor in Olive Tree Compounding Pharmacy's latest funding round was Colony Bank. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Olive Tree Compounding Pharmacy's history?
The largest funding round in Olive Tree Compounding Pharmacy's history was $150K.
See more information about Olive Tree Compounding Pharmacy